Free patient guide · 19 pages · PDF

Stem Cell Therapy for Diabetes: A Patient's Guide

Regenerating Pancreatic Function and Improving Glucose Control

Last updated: 2026-09-01 · Medically reviewed by SCL Medical Team

Download the free PDF (19 pages)Book a free consultation

What is inside this guide

Understanding Diabetes
How Stem Cell Therapy Helps
Treatment at StemCell Longevita
Results & Recovery
Getting Started

Chapter 1

Understanding Diabetes

What Is Diabetes?

Diabetes mellitus is a chronic metabolic disease characterized by elevated blood glucose levels due to insufficient insulin production (Type 1), insulin resistance (Type 2), or both. It affects over 537 million adults worldwide. Uncontrolled diabetes leads to progressive damage to blood vessels, nerves, kidneys, eyes, and heart, making it a leading cause of blindness, kidney failure, heart attacks, and lower limb amputation.

Types and Complications

The progressive loss of beta cell mass and function is central to diabetes progression. Stem cell therapy offers the potential to regenerate beta cells and restore the body's natural insulin-producing capacity.

Type 1 Diabetes — Autoimmune destruction of insulin-producing beta cells in the pancreas, requiring lifelong insulin therapy.
Type 2 Diabetes — Progressive insulin resistance and declining beta cell function, often associated with obesity and lifestyle factors.
Diabetic Neuropathy — Nerve damage causing numbness, pain, and weakness, particularly in the extremities.
Diabetic Nephropathy — Progressive kidney damage that can lead to dialysis or kidney transplant.
Cardiovascular complications — Accelerated atherosclerosis increasing risk of heart attack and stroke.

Chapter 2

How Stem Cell Therapy Helps

Pancreatic Regeneration

MSC therapy for diabetes works through multiple mechanisms: stimulating the regeneration of beta cells in the pancreatic islets, improving insulin sensitivity in peripheral tissues, reducing the chronic inflammation that contributes to insulin resistance, and protecting remaining beta cells from further damage. For Type 1 diabetes, immune modulation helps reduce the autoimmune attack on beta cells. A clinical trial published in Diabetes Care demonstrated that MSC infusion in Type 2 diabetes patients reduced HbA1c by an average of 1.5 percentage points and reduced insulin requirements by 30-50% at 12-month follow-up.

Measurable Outcomes

1.5%: Average HbA1c Reduction
35%: Reduced Insulin Requirements
73%: Improved Glucose Control

Figures reported in our own patient guide from published studies and our clinical experience. They describe groups of patients, not a prediction for any individual case. See the evidence we rely on.

Chapter 3

Treatment at StemCell Longevita

Our Diabetes Protocol

Our diabetes treatment protocol combines IV stem cell infusion for systemic metabolic improvement with targeted pancreatic delivery where appropriate. Treatment is customized based on diabetes type, duration, current medications, and the extent of complications. We use high-dose umbilical cord-derived MSCs known for their potent immunomodulatory and regenerative properties.

Treatment Process

Day 1 — Comprehensive metabolic evaluation including HbA1c, C-peptide levels, insulin levels, lipid panel, and complication screening at Liv Hospital Ulus.
Day 2-3 — Sequential IV stem cell infusions with blood glucose monitoring throughout treatment.
Day 4 — Post-treatment assessment, medication adjustment guidance, and long-term management plan.

Chapter 4

Results & Recovery

Expected Improvements

Blood glucose improvements typically begin within 4 to 8 weeks. HbA1c improvements are measurable at 3 months. Reduced medication and insulin requirements develop over 3 to 6 months. Improvements in diabetic complications (neuropathy, nephropathy) may develop over 6 to 12 months.

4-8: Weeks to Glucose Improvement
78%: Improved HbA1c Levels
18+: Months of Sustained Benefits

Figures reported in our own patient guide from published studies and our clinical experience. They describe groups of patients, not a prediction for any individual case. See the evidence we rely on.

Chapter 5

Getting Started

Candidacy and Next Steps

Stem cell therapy may benefit Type 1 and Type 2 diabetes patients who desire better glucose control, want to reduce medication burden, or are developing complications. Send your recent lab work and medical history for a free evaluation and treatment recommendation.

Frequently asked questions

While a complete cure is not currently achievable, stem cell therapy can significantly improve glucose control, reduce medication needs, and slow the progression of diabetic complications. Ongoing research continues to advance toward more definitive treatments.

Yes, though through different mechanisms. For Type 1, the focus is on immune modulation and beta cell regeneration. For Type 2, it addresses insulin resistance and supports remaining beta cell function. Both types can benefit from treatment.

Some Type 2 diabetes patients have been able to significantly reduce or discontinue insulin after stem cell therapy. Type 1 patients typically still require insulin but at reduced doses. Any medication changes should be made under medical supervision.

Our team closely monitors blood glucose levels throughout the treatment period and makes real-time adjustments to diabetes medications as needed to maintain optimal glucose control.

Next steps

Download the full guide for the complete chapters, clinical detail and the questions to ask any clinic. Our team reviews every enquiry personally and will tell you honestly whether this therapy is appropriate for your case.